Table 2. b-LMB has anti-cancer activity that is less potent than unmodified LMB in a cellular cytotoxicity assay.
Cell Line | Selinexor IC50 (nM) | LMB IC50 (nM) | b-LMB IC50 (nM) |
---|---|---|---|
MM.1S | 20 | 0.46 | 3.1 |
HCT-116 | 50 | 0.19 | 6.0 |
AML2 | 90 | 0.39 | 2.53 |
AML3 | 270 | 0.68 | 4.68 |